After a monumental last week for the psychedelics sector, we’re back with another edition of Weekly Extractions. In this episode, Adam Tubero reviews why you shouldn’t be sleeping on Gilgamesh Pharmaceuticals and reviews the programs they have running. He also goes over Field Trip’s recent clinical trial developments, Compass Pathways’ new executive hire, and as…